JBS tried to buy out Pilgrim’s Pride at a $26.50 cash price—then withdrew after the special committee rejected the valuation

In August 2021, JBS proposed to acquire all remaining publicly traded shares of Pilgrim’s Pride that it did not already own—explicitly positioned as a path to take the company fully private. The economics were straightforward on paper: JBS offered $26.50 per share in cash for the outstanding minority stake.

A squeeze-out offer can be read as a market forecast. JBS’s initial price of $26.50—and its later increase to $28.50—implied that it believed the combination of (1) poultry-margin recovery/normalization and (2) operational and ownership synergies would make buying the remaining float accretive versus the premium it was paying.

But Pilgrim’s Pride’s special committee rejected the logic. In its process, the committee stated that the proposal “does not appropriately value” shares owned by shareholders other than JBS—i.e., minority holders were effectively granted a “valuation floor” higher than JBS’s implied sum of margin confidence + consolidation gains.

For protein processors, margins swing with feed costs, live-bird availability, demand cycles, and plant-level execution. That makes minority pricing in a go-private framework sensitive: the buyer has to underwrite not only base-case profitability, but also the probability of margin mean-reversion behaving favorably over the buyer’s ownership horizon.

Here’s the pressure point: when a buyer is trying to remove minority risk and control the full capital structure, it typically leans on (a) operational leverage after integration and (b) the ability to smooth strategy through the cycle. The committee’s rejection suggests those benefits weren’t enough—at JBS’s proposed price—to clear the minority valuation threshold.

Financial performance volatility is exactly what makes minority premium math contentious. Over FY2020–FY2025, Pilgrim’s Pride reported large changes in profitability (with FY2021 notably weak), which increases the chance that a buyer’s forecast diverges from what minority holders demand as a control-premium buffer.

Against that backdrop, the committee’s posture in the filings is consistent with a view that “margin strength” alone shouldn’t justify paying only the buyer’s private assumptions. The gap was ultimately about valuation appropriateness, not whether poultry margins can improve.

This wasn’t a simple majority-controlled squeeze. JBS’s unsolicited proposal triggered governance protections. Pilgrim’s Pride formed a special committee of independent directors to review and evaluate the offer, and then set a hard constraint: it would not support the proposal unless JBS significantly increased the purchase price.

JBS did increase price (from $26.50 to $28.50), but the special committee still rejected the revised offer (noting it undervalued publicly owned shares). The final outcome: JBS withdrew the proposal and the committee indicated it would suspend operations after the withdrawal.

A successful take-private would typically reduce public-market scrutiny and replace it with private-owner decision-making. Minority holders therefore discount less for governance loss if (and only if) they’re compensated for the increased uncertainty and reduced liquidity.

That’s why the minority premium math is not theoretical here: the committee’s rejection and JBS’s withdrawal together indicate that JBS was not willing to pay enough control value to neutralize minority uncertainty.

The topic framing highlights JBS’s long-running desire to build or simplify its US structure. Even though the take-private attempt failed, the behavior—making an unsolicited full-control bid—still reflects a control-first approach to managing the US poultry asset within JBS’s broader strategy.

What remains unanswerable from primary filings opened here: whether the next steps involved explicit US listing mechanics tied to this specific episode. The SEC documents reviewed establish the proposal price, committee rejection, and withdrawal; they do not disclose a completed listing timetable.